June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Macular pigment optical density in healthy and patients with open angle glaucoma
Author Affiliations & Notes
  • Jessica Yvette Lee
    Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA
    College of Optometry, Western University of Health Sciences, Pomona, CA
  • Katia Suarez-Berumen
    College of Osteopathic Medicine of the Pacific (COMP), Western University of Health Sciences, Pomona, CA
  • Kiana Nouri
    College of Osteopathic Medicine of the Pacific (COMP), Western University of Health Sciences, Pomona, CA
  • Emily Cook
    Ophthalmology, Southern California Glaucoma Consultants, Pasadena, CA
  • Alfred Solish
    Ophthalmology, Southern California Glaucoma Consultants, Pasadena, CA
  • Pinakin Davey
    College of Optometry, Western University of Health Sciences, Pomona, CA
  • Footnotes
    Commercial Relationships Jessica Lee, None; Katia Suarez-Berumen, None; Kiana Nouri, None; Emily Cook, None; Alfred Solish, None; Pinakin Davey, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1037. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jessica Yvette Lee, Katia Suarez-Berumen, Kiana Nouri, Emily Cook, Alfred Solish, Pinakin Davey; Macular pigment optical density in healthy and patients with open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1037.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The macular pigment optical density (MPOD) potentially quench the free radicals and the reactive oxidative species in the retina and may be protective to the ganglion cells, photoreceptors and retinal pigment epithelial layer. One could postulate that patients with accelerated death of ganglion cells like open angle glaucoma could have decreased level of MPOD due to its pathophysiology. We sought to investigate the level of MPOD in patients with glaucoma and compare it to MPOD in ocular healthy individuals.

Methods: The MPOD was measured in 82 individuals (44 ocular healthy and 38 glaucoma patients) using the QuantifEye heterochromatic flicker photometer in their dominant eye. The statistical analysis was performed to evaluate the difference in number of males and females, correlation between MPOD & age and evaluate the difference in level of MPOD as a function of age, gender and diagnosis.

Results: The males to females ratio was significantly different in the glaucoma group versus ocular healthy group (Chi-square test p=0.01) however the level of MPOD did not vary as a function of gender (t-test p =0 39). Overall there was no association between age and MPOD (Pearson correlation r=0.03; p=0.6). The mean MPOD in the ocular healthy group was lesser than the glaucoma group 0.45 (SD 0.16) and 0.56 (SD 0.16) respectively which was significantly different (independent samples t-test t-statistic=-2.87; p=0.005).

Conclusions: The macular pigment optical density in this study was greater in glaucoma group compared to ocular healthy group. This result contradicts prior published literature (Igras et al Br J Ophthalmol. 2013). Further research is warranted to investigate the reasons for the different findings in these studies to further understand the role of MPOD in glaucoma pathogenesis.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×